Hôpital Saint Joseph — Marseille

Public research footprint of Hôpital Saint Joseph, compiled from the ClinicalTrials.gov public registry.

148

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer (NSCLC) · Stage IIB-III NSCLC · Ovarian Cancer Stage IV · Hepatocellular Carcinoma

Recently updated registry entries

NCT05443087 — TARGETed Therapy Drug MONITOring in DIGestive Oncology (Recruiting)
NCT06170788 — Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab… (Recruiting)
NCT05476796 — Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Saint Joseph?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.